EUVIMEDEUVIMED entdecken
Crossref

Encapsulation of 4-oxo- N -(4-hydroxyphenyl) retinamide in human serum albumin nanoparticles promotes EZH2 degradation in preclinical neuroblastoma models

Boddu Mrunalini, Atul Dev, Avinash Chandra Kushwaha, Mohammed Nadim Sardoiwala, Surajit Karmakar

Nanoscale · 2024

DOI: 10.1039/d4nr00642a ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale, 2024. Verfasst von Boddu Mrunalini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali 140306, India. surajit@inst.ac.in. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Neuroblastoma, Nanoparticles. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, Council of Scientific and Industrial Research, India, Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schematic represents 4O4HPR loaded HSANPs directing the proteasomal degradation of the polycomb group of the protein, EZH2, by triggering oxidative stress and PKC-δ activation, leading to the killing of neuroblastoma cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer of Zeste Homolog 2 ProteinNeuroblastomaNanoparticlesHumansAnimalsCell Line, TumorMiceSerum Albumin, HumanApoptosisFenretinideReactive Oxygen SpeciesMice, NudeProteolysisMembrane Potential, MitochondrialXenograft Model Antitumor AssaysAntineoplastic AgentsCaspase 3

Substanzen

Enhancer of Zeste Homolog 2 ProteinEZH2 protein, humanSerum Albumin, HumanFenretinideReactive Oxygen SpeciesAntineoplastic AgentsCaspase 3

Autor:innen und Institutionen

  • Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali 140306, India. surajit@inst.ac.in.

Förderung

  • Department of Science and Technology, Ministry of Science and Technology
  • Council of Scientific and Industrial Research, India
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Indian Council of Medical Research

Zitieren

APA

Mrunalini, B., Dev, A., Kushwaha, A. C., Sardoiwala, M. N., & Karmakar, S. (2024). Encapsulation of 4-oxo- N -(4-hydroxyphenyl) retinamide in human serum albumin nanoparticles promotes EZH2 degradation in preclinical neuroblastoma models. Nanoscale. https://doi.org/10.1039/d4nr00642a

Vancouver

Mrunalini B, Dev A, Kushwaha AC, Sardoiwala MN, Karmakar S. Encapsulation of 4-oxo- N -(4-hydroxyphenyl) retinamide in human serum albumin nanoparticles promotes EZH2 degradation in preclinical neuroblastoma models. Nanoscale. 2024. doi:10.1039/d4nr00642a

BibTeX
@article{Mrunalini2024,
  author = {Mrunalini, Boddu and Dev, Atul and Kushwaha, Avinash Chandra and Sardoiwala, Mohammed Nadim and Karmakar, Surajit},
  title = {Encapsulation of 4-oxo- N -(4-hydroxyphenyl) retinamide in human serum albumin nanoparticles promotes EZH2 degradation in preclinical neuroblastoma models},
  journal = {Nanoscale},
  year = {2024},
  doi = {10.1039/d4nr00642a}
}
Kostenlos starten →